Development of novel small molecules to target cellular pathways

B2FIND2026-04-25 收录

药物靶点发现

分子结构表征

数据链接：

https://b2find.eudat.eu/dataset/ac8ebec7-5e5b-5ac2-93bc-c6e07b615325 数据链接链接失效反馈

官方服务：

资源简介：

Small molecules represent powerful tools to dissect physiological and pathological states of signaling pathways, yet require characterization through X-ray crystallography. This...

Novel cancer-selective and disease subtype-independent mechanistic targets of withaferin A in human breast cancer cells

药物靶点发现

乳腺癌分子机制

We report differential gene expression changes by withaferin A in breast cancer cells versus a normal mammary epithelial cell line. Overall design: Examination of withaferin A-regulated transcriptome

NIAID Data Ecosystem40

The ROCK Inhibitor Fasudil and Sertraline Share Morphological and Molecular Effects in the Hippocampus of Chronically Stressed Rats: Exploring Common Antidepressant Pathways by Network Pharmacology

抑郁症神经药理学

药物靶点发现

Despite the widespread use of selective serotonin reuptake inhibitors like sertraline, the intricate molecular mechanisms underlying major depression and the therapeutic efficacy of these treatments r

Figshare2025-04-03 更新10

Combining Neurobehavioral Analysis and In Vivo Photoaffinity Labeling to Understand Protein Targets of Methamphetamine in Casper Zebrafish

药物靶点发现

神经药理学

Photoaffinity labeling (PAL) remains one of the most widely utilized methods of determining protein targets of drugs. Although useful, the scope of this technique has been limited to in vitro applicat

Figshare2020-07-30 更新00

Table_1_Exploring novel targets of sitagliptin for type 2 diabetes mellitus: Network pharmacology, molecular docking, molecular dynamics simulation, and SPR approaches.docx

药物靶点发现

糖尿病机制

BackgroundDiabetes has become a serious global public health problem. With the increasing prevalence of type 2 diabetes mellitus (T2DM), the incidence of complications of T2DM is also on the rise. Sit

NIAID Data Ecosystem20

Deciphering Opioid Peptide Binding Modes at Atypical Chemokine Receptor 3

受体-配体结合模拟

药物靶点发现

ACKR3 is a class A G protein-coupled receptor that is considered as an atypical chemokine receptor. It does not activate G proteins but efficiently recruits β-arrestin and mediates ligand internalizat

Figshare00

Development of novel small molecules to target cellular pathways

资源简介：

相关数据集